Aggregator
The brain struggles to make new neurons in people with depression
How to manage AI risks while reaping the benefits
Asthma in some boys stops at puberty: mouse results hint at why
Ancient surveying instrument found in Egypt
Addendum: Sea level much higher than assumed in most coastal hazard assessments
These rodent OnlyFans stars are helping to fund scientific research
How tech-enhanced sleep could improve rest but erode privacy
China is changing the shape of global health. The terms are still up for negotiation
How one researcher captured a vanished world of UK government science
A guide to securing your first research fellowship: what reviewers are looking for
Assessing students in the AI era
Protecting education in the middle of war zones
The future of peer review requires AI support, not AI bans
Amend copyright licences to halt AI misuse and reassert human control
Researchers presented 6000 papers at a major meeting. Could AI reproduce their findings?
Hackathon results suggest AI agents could make verifying research far more routine
Depression may shut down the brain’s ability to make new neurons
A major study found that adults with depression show disrupted production of new neurons in the hippocampus, potentially weakening the brain’s ability to separate new experiences from painful memories. The researchers also identified broad molecular changes that could open the door to new treatments tailored to different biological forms of depression.
Worldwide study of diseases gets historic funding influx
Gates Foundation pledges $540 million to a project often criticized for its opacity
People who live past 110 have an unusual abundance of killer immune cells
People who reach 110 and beyond appear to have unusually large numbers of rare immune cells capable of killing abnormal cells. These CD4 cytotoxic T cells became more common with age and often expanded into large groups of nearly identical cells, suggesting the immune system was repeatedly responding to persistent threats.
In a global first, Mexico approves use of RNA-based fungicide
Oifirax, created by GreenLight Biosciences, uses RNA molecules to kill the fungus responsible for powdery mildew on grapes
This is what a Jurassic forest may have sounded like
Researchers re-create the chorus of noise produced by ancient insects